Zemplar

Paricalcitol, sold under the brand name Zemplar, is a vitamin D analog prescribed to manage secondary hyperparathyroidism in patients with chronic kidney disease. This medication helps regulate calcium and phosphorus levels in the bloodstream. It is administered intravenously during haemodialysis sessions. Paricalcitol supports bone health and reduces parathyroid hormone levels effectively.

Paricalcitol is primarily used to treat secondary hyperparathyroidism in adults undergoing chronic kidney dialysis. It works by mimicking the action of vitamin D to lower elevated parathyroid hormone levels. This medication is specifically designed for patients whose kidneys no longer adequately regulate these hormones. It helps maintain balanced calcium and phosphorus levels, supporting overall metabolic health.

Many patients report improved energy levels and reduced symptoms of bone discomfort after starting paricalcitol therapy. Some individuals may experience mild gastrointestinal effects such as nausea or vomiting during treatment. These effects are generally temporary and tend to diminish as the body adjusts to the medication. Regular monitoring helps ensure the medication is well-tolerated over time.

Paricalcitol should be used under medical supervision, particularly for patients with a history of high calcium levels or vitamin D toxicity. Blood calcium and phosphorus levels require regular monitoring to avoid complications. Patients should inform their healthcare provider about all current medications and health conditions before starting this treatment. Avoid self-adjusting doses without professional guidance.

Certain medications, including strong CYP3A4 inhibitors and calcium supplements, may interact with paricalcitol. Patients taking digoxin or other heart medications should exercise caution due to potential calcium level fluctuations. Herbal supplements and over-the-counter vitamins containing vitamin D or calcium may also affect treatment outcomes. Always disclose all medications to your healthcare provider.